CORVAC Trademark

Trademark Overview


On Tuesday, August 18, 2020, a trademark application was filed for CORVAC with the United States Patent and Trademark Office. The USPTO has given the CORVAC trademark a serial number of 79296041. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by BioNTech RNA Pharmaceuticals GmbH. The CORVAC trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and other immunological diseases, in particular by means of nucleic acids, self-replicating nucleic acids, viruses, virus-like particles, peptides and proteins; nucleic acids coding for receptor proteins for the stimulation and proliferation of cells of the immune system for medical purposes; all the foregoing for human use

Medical services, in particular providing therapeutic methods and vaccination methods for the treatment and prevention of cancer, infectious diseases and immunological diseases; medical and pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services; medical services relating to information in the nature of providing medical information, the rendering of medical advice in the field of the prevention and the treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use

Medical and scientific research, in particular in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; scientific research services relating to pharmaceutical information, the rendering of scientific research advice in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
corvac

General Information


Serial Number79296041
Word MarkCORVAC
Filing DateTuesday, August 18, 2020
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6749038
Registration DateTuesday, June 7, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and other immunological diseases, in particular by means of nucleic acids, self-replicating nucleic acids, viruses, virus-like particles, peptides and proteins; nucleic acids coding for receptor proteins for the stimulation and proliferation of cells of the immune system for medical purposes; all the foregoing for human use
Goods and ServicesMedical services, in particular providing therapeutic methods and vaccination methods for the treatment and prevention of cancer, infectious diseases and immunological diseases; medical and pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services; medical services relating to information in the nature of providing medical information, the rendering of medical advice in the field of the prevention and the treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
Goods and ServicesMedical and scientific research, in particular in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; scientific research services relating to pharmaceutical information, the rendering of scientific research advice in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 19, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioNTech SE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameBioNTech SE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameBioNTech SE
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressDE

Party NameBioNTech RNA Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Monday, September 19, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 19, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 7, 2022EXPARTE APPEAL TERMINATED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 15, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, April 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, March 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 6, 2022EX PARTE APPEAL-INSTITUTED
Thursday, January 6, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, January 6, 2022EXPARTE APPEAL RECEIVED AT TTAB
Friday, December 31, 2021CHANGE OF OWNER RECEIVED FROM IB
Thursday, December 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 30, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, July 8, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 8, 2021FINAL REFUSAL E-MAILED
Thursday, July 8, 2021FINAL REFUSAL WRITTEN
Friday, July 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 24, 2021REFUSAL PROCESSED BY IB
Tuesday, January 5, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 4, 2021REFUSAL PROCESSED BY MPU
Thursday, December 17, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 16, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 15, 2020ASSIGNED TO EXAMINER
Friday, October 23, 2020APPLICATION FILING RECEIPT MAILED
Monday, October 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 15, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB